Takeover talk swirls around Onyx; Pfizer sues Watson over generic Pristiq app;

@FiercePharma: Check out our special report: Pharma's Top 10 Marketing Settlements. Approx. $11 bn over 10 years. Special Report | Follow @FiercePharma

> Onyx Pharmaceuticals ($ONXX) is analysts' latest favorite takeover target, now that its experimental drug carfilzomib has drawn support from an FDA advisory panel and could be approved as soon as next month. Report

> Watson Pharmaceuticals ($WPI) asked FDA to approve its version of the Pfizer ($PFE) antidepressant Pristiq, and Pfizer sued to block the copycat drug. Report

> Spanish drugmaker Faes Farma says its earnings are threatened by payment delays from regional governments that are forcing pharmacies out of business. Report

> Japan's Daiichi Sankyo won FDA approval to start work at a new packaging plant in Pennsylvania, planning to take some outsourced operations back in-house. Report

> Russia's Veropharm posted first-quarter profits of 494.3 million roubles, or $14.83 million, a 46% increase, fueled by rising demand for prescription drugs. Report

> Cholesterol-fighting statin drugs work as well at preventing heart problems in women as they do in men. Report

Biotech News

 @FierceBiotech: Promising RA antibody data may help encourage new Ablynx partnership. Story | Follow @FierceBiotech

 @JohnCFierce: Does this controversy have legs? Maybe so. FDA review cites Amylin for withholding data on Bydureon app. Story | Follow @JohnCFierce

 @RyanMFierce: My interviews with eclinical CEOs at DIA 2012 about mobile, remote site monitoring, Microsoft partnerships: More | Follow @RyanMFierce

> R&D numbers point to a turnaround in pipeline productivity. Report

> Quintiles to offer new jobs to 100 axed Merck Serono staffers. Story

> Analysts conjure up images of a dream buyout deal for Onyx. Article

Medical Device News

@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

@MarkHFierce: Another day, another deal closes. Covidien is now the proud new owner of Oridion Systems. The cost: $310M. Release | Follow @MarkHFierce

 @DamianFierce: Getting ahead of the pending device tax, Stryker has started its rolling layoffs, looking to cut 107 jobs. More | Follow @DamianFierce

> FDA OKs first glaucoma stent for cataract surgery. News

> User fee bill heads to White House. Story

> Following the U.K., FDA wants to take a hard look at hip implants. Article

Biotech Research News

> Scientists wield human stem cells to engineer blood-brain barrier structures. Story

> Cleveland BioLabs drug, chemo kill neuroblastomas in mice. Item

> U.K. researchers enhance tracking for stem cell injections. Article

> At long last, 2nd controversial look at bird flu virus finally published. More

Pharma Manufacturing News

> Sanofi plant problems result in vaccine shortage. News

> Novartis plant in Russia two years out. More

> Fake Viagra apparently sourced in China. Article

> Import alert lifted for AkzoNobel Mexico plant. Story

And Finally... The 2009 swine flu pandemic may have killed 15 times more people around the world than previously thought. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.